MedPath

VEKLURY

VEKLURY

Approved
DIN Number

02502143

Drug Class

Human

Market Date

Oct 16, 2020

Company
HC

gilead sciences canada inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02502143
AIG Number0162395002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
J05AB16 REMDESIVIR
Product Specifications
Dosage FormPowder For Solution
Route of AdministrationIntravenous
AHFS Classification08:18.32
Health Canada Classification

ACTIVE INGREDIENTS (1)

REMDESIVIRActive
Strength: 100 MG / VIAL
Monograph: REMDESIVIR

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.